Lynn DeBar, PhD, is a clinical psychologist and behavioral health researcher. Her work focuses on health issues that have emotional and physical causes and manifestations, including pain syndromes, eating disorders, and obesity-related health problems. She is particularly interested in exploring how these health issues can be addressed and treated in primary-care settings, and the role of behaviorally oriented interdisciplinary approaches as well as complementary and integrative health practices in this treatment.
Dr. DeBar’s work builds on research showing that people with emotional disorders, such as anxiety and depression, often seek treatment for related physical symptoms, and that people with a variety of physical ailments can benefit greatly from concomitant attention to their emotional and psychosocial conditions. Accordingly, Dr. DeBar develops and evaluates treatment approaches that simultaneously address these complex physical and emotional needs. Dr. DeBar works closely with physicians at Kaiser Permanente and other health care systems to ensure that her research findings make their way into clinical practice, and to identify real-world clinical practices that have the potential to improve service delivery through large-scale adoption of behavioral and lifestyle interventions.
Dr. DeBar holds a PhD in clinical and community psychology with an emphasis on health psychology from Yale University. Dr. DeBar also received an MPH from Oregon Health & Sciences University, where she focused on epidemiology and biostatistics. From 2002 to 2017, Dr. DeBar was a Senior Investigator at CHR. In 2017, she took a position as a Senior Scientist at the Kaiser Permanente Washington Health Research Institute. She is continuing the research studies she started in CHR as a Senior Affiliate Investigator, and plans to serve as a bridge between the two research units.
- Larson E, Tachibana C, Thompson E, Coronado G, DeBar L, Dember LM, Honda S, Huang SS, Jarvik JD, Nelson C, Septimus E, Simon G, Johnson KE. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems. Healthcare. (2015) Doi:10.1016/j.hjdsi.2015.07.005i
- Bussing R, Narwaney KJ, Winterstein A, Newton DA, DeBar LL, et al. Pharmacotherapy for incident Attention-Deficit/Hyperactivity Disorder: Practice patterns and quality metrics. Journal of Child and Adolescent Psychopharmacology Curr Med Res Opin. 2014 Aug;30(8):1687-99 [Epub 2014 Apr 7]
- Daley MF, Newton DA, DeBar L, Newcomer SR, Pieper L, Boscarino JA, Toh S, Pawloski P, Nordin JD, Nakasato C, Herrinton LJ, Bussing R. Accuracy of electronic health record derived data for the identification of incident Attention-Deficit/Hyperactivity Disorder (ADHD). J Atten Disord. 2014 Feb 7. [Epub ahead of print]
- Jago R, Drews KL, Otvos JD, Foster GD, Marcus MD, Buse JB, Mietus-Snyder M, Willi SM; HEALTHY Study Group. Effect of relative weight group change on nuclear magnetic resonance spectroscopy derived lipoprotein particle size and concentrations among adolescents. J Pediatr. 2014 May;164(5):1091-1098.e3. doi: 10.1016/j.jpeds.2013.12.029. Epub 2014 Feb 5.
- Raebel MA1, Newcomer SR, Bayliss EA, Boudreau D, DeBar L, Elliott TE, Ahmed AT, Pawloski PA, Fisher D, Toh S, Donahoo WT. Chronic opioid use emerging after bariatric surgery. Pharmacoepidemiol Drug Saf. 2014 Dec;23(12):1247-57. doi: 10.1002/pds.3625. Epub 2014 Apr 14